Phibro acquired Zoetis' MFA business, and JPMorgan analysts raised price targets and upgraded stock.

1 report, 0 independent Updated Jul 8

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

JPMorgan Chase Phibro Zoetis

Keep exploring

Part of

Phibro's MFA portfolio grew while Zoetis' MFA portfolio exceeded expectations on August 28, 2025. All 1 developments

The entities involved

JPMorgan Chase
American multinational banking and financial services holding company
- Goldman Sachs, Morgan Stanley, JPMorgan Chase, and Bank of America are competing in the global investment banking sector.Mon 17:24
- JPMorgan Chase began analyst coverage with an Overweight rating on Alkami Technology, Inc. on June 26, 2025.Mon 02:31
Phibro
international physical commodities trading firm
- Phibro and Dare Bioscience are both small-cap healthcare companies developing products for women's health in the United States.Thu 05:48
Zoetis
American animal health company

Nothing else this week.

Coverage

Newest first; wire copies grouped

Jul 8Unknown outlet